Butyrate Increases Heparin Synthesis and Storage in Human Mast Cells.
berberine
butyrate
heparin
mast cells
sulfated glycosaminoglycan
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
24 Jul 2024
24 Jul 2024
Historique:
received:
16
05
2024
revised:
15
07
2024
accepted:
17
07
2024
medline:
9
8
2024
pubmed:
9
8
2024
entrez:
9
8
2024
Statut:
epublish
Résumé
Sulphated glycosaminoglycans (GAGs) such as heparin are a major component of mast cell granules and form the matrix within which biogenic mediators are stored. Since GAGs released from mast cells also play an important role in helminth expulsion, understanding GAG storage can offer new insights into mast cell function. Sodium butyrate (NaBu), a short-chain fatty acid, causes ultrastructural changes within the granules of human mast cells (HMC-1) and increases their histamine content. Therefore, we hypothesized that NaBu treatment would also modify the storage of polysaccharides such as GAGs. NaBu (1 mM) significantly increased GAG content and granularity in a time- and concentration-dependent manner without affecting cell viability and metabolic activity. NaBu increased the expression of enzymes associated with heparin biosynthesis (
Identifiants
pubmed: 39120272
pii: cells13151241
doi: 10.3390/cells13151241
pii:
doi:
Substances chimiques
Heparin
9005-49-6
Butyrates
0
Butyric Acid
107-92-6
Cholesterol Esters
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Research Council Canada, Natural Sciences and Engineering Research Council
ID : NA